Association of Pediatric ASPECTS and NIH Stroke Scale, Hemorrhagic Transformation, and 12-Month Outcome in Children With Acute Ischemic Stroke
Beslow L, Vossough A, Ichord R, Slavova N, Yau M, Gajera J, Stojanovski B, Adil M, Breimann J, Kimmel A, Mackay M. Association of Pediatric ASPECTS and NIH Stroke Scale, Hemorrhagic Transformation, and 12-Month Outcome in Children With Acute Ischemic Stroke. Neurology 2021, 97: e1202-e1209. PMID: 34389646, DOI: 10.1212/wnl.0000000000012558.Peer-Reviewed Original ResearchAcute arterial ischemic strokeHemorrhagic transformationIschemic strokeFunctional outcomePedNIHSS scoreStroke severityAlberta Stroke Program Early CT ScoreAcute supratentorial ischemic strokeNIH Stroke Scale scoreRoyal Children's Hospital MelbournePediatric Stroke Outcome MeasureAcute revascularization therapyClinical stroke severitySymptomatic intracranial hemorrhageArterial ischemic strokeClass II evidenceStroke risk factorsStroke Scale scoreAcute ischemic strokeSupratentorial ischemic strokeNIH Stroke ScaleFuture pediatric studiesStroke Outcome MeasureYears of agePresence of tumorEndovascular and thrombolytic treatment eligibility in childhood arterial ischemic stroke
Hutchinson M, Beslow L, Shih E, Licht D, Kimmel A, Granath C, Ichord R. Endovascular and thrombolytic treatment eligibility in childhood arterial ischemic stroke. European Journal Of Paediatric Neurology 2021, 34: 99-104. PMID: 34454335, DOI: 10.1016/j.ejpn.2021.08.004.Peer-Reviewed Original ResearchConceptsAcute ischemic strokeLarge vessel occlusionEndovascular therapyHyperacute therapyIV-tPAVessel occlusionIschemic strokeMedical contraindicationsScore 6Childhood arterial ischemic strokeIntravenous tissue plasminogen activatorNIH Stroke Scale scoreArterial ischemic strokeStroke Scale scoreSingle-center cohortMild neurologic deficitsTime of presentationComplete vessel occlusionTissue plasminogen activatorChildren ages 2Hyperacute treatmentClinical characteristicsNeurologic deficitsStroke pathwayTreatment eligibility